CASTRATE SENSITIVE PROSTATE CANCER
Clinical trials for CASTRATE SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Veterans study to reveal best prostate cancer pill
Disease control Recruiting nowThis phase 2 trial is testing three different drugs—abiraterone acetate, enzalutamide, and apalutamide—in 192 veterans with castrate-sensitive prostate cancer that has spread. The goal is to see which drug works best as a first treatment when combined with hormone therapy. Resear…
Matched conditions: CASTRATE SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Walking or cycling at home may ease fatigue in prostate cancer patients
Symptom relief Recruiting nowThis study tests whether two home-based exercise programs—walking or high-intensity cycling—can improve fitness and reduce fatigue in men with metastatic prostate cancer who are starting hormone therapy. Twenty-four participants will exercise at home for 12 weeks, with remote mon…
Matched conditions: CASTRATE SENSITIVE PROSTATE CANCER
Phase: NA • Sponsor: Paul Viscuse • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC